Navigation Links
SPIE and Laurin Publishing Announce Prism Awards Finalists
Date:1/13/2009

the awards in the first year was very strong, and the products and processes submitted for review are world-class. They reflect both the leadership and expertise of the organizations in this field."

Finalists for the Prism Awards for Photonics Innovation are listed below and can be viewed online at www.PrismAward.org, SPIE.org/photonics-west.xml and photonics.com.

SPIE is the international optics and photonics society founded in 1955 to advance light-based technologies. Serving the interests of its more than 188,000 active constituents representing 138 different countries, SPIE acts as a catalyst for collaboration among technical disciplines for information exchange, continuing education, publishing opportunities, patent precedent, and career and professional growth. As the organizer and sponsor of approximately 25 major conferences and education programs annually in North America, Europe, Asia, and the South Pacific, SPIE provides publishing, speaking, and learning opportunities on emerging technologies. SPIE contributes more than $1.6 million annually in scholarships, grants, and other programs supporting research and education around the world. For more information, visit SPIE.org.

Laurin Publishing is located in Pittsfield, MA, with additional offices throughout the world. Under Photonics Media, the company publishes Photonics Spectra, Biophotonics International, EuroPhotonics, The Photonics Showcase, The Photonics Directory and Photonics.com. For more information visit www.photonics.com.

Prism Awards for Photonics Innovation 2008 Finalists

    4D Technology
    Applied Scintil
'/>"/>
SOURCE  Laurin Publishing
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
2. Three Expert Opinion Journals now Publishing Original Research
3. Jubilant and BioLeap Announce New Partnership in Drug Discovery
4. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
5. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
6. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
7. Neurobiological Technologies Announces Suspension of Viprinex Development
8. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
9. Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services
10. Varian, Inc. Announces Online Experience
11. Victhom announces the completion of the second phase of the apnea therapy development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 EUCODIS Bioscience, a company,d...ng enzymes for the,chemical industry announced tod...ith Bio Sidus, the leading biopharmaceutical compa...s EUCODIS Bioscience exclusive access - for the se...etary collection of,psychrophilic bacteria strains...
(Date:11/6/2009)...wswire/ -- Intarcia Therapeutics, Inc. delivered t...; continuous delivery of exenatide) program for th... Diabetes Technology Meeting in San Francisco, CA:.../20050301/SFTU126LOGO ) ,, Continuous Subcuta...asma Glucose, HbA1c and Reduces Weight in a 28-day...
(Date:11/5/2009)...Newswire/ -- The endangered black-footed ferrets i... rare carnivore feeds on prairie dogs. The prair...ntire population die-offs in towns occur. The U.S...d a ferret breeding program and has been releasing...ve habitat. Unfortunately, plague can sweep throu...
(Date:11/5/2009)...November 5, 2009 at 4:30 p.m. Eastern Time , ...Call/ - OncoGenex Pharmaceuticals, Inc. ("OncoGene...ed unaudited financial results for the third quart...viewed the Company,s highlights for the third quar...lts reflect the operations of OncoGenex Technologi...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...provider of centralized ECG and eClinical technolo...cal, medical device, and related industries, annou...o of products and services on Booth #1253/1254 at ...in Berlin, Germany. ERT is also inviting attendees...e impact of technology and standards on drug deliv...
...orate partially absorbable mesh for use in the tre...d to improve healing and patient comfort , , SO...amp; Urology, a division of Ethicon, Inc., a Johns... GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System...surgery to treat pelvic organ prolapse. GYNECARE P...
...arma Ltd., a,privately-held drug development compa...ed that it has begun a new Phase IIa clinical test... novel topical drug for,dermatology. The double-bl...ate the tolerability, pharmacokinetics, and effica...s with mild to moderate plaque psoriasis. The,subj...
Other Biology Technology:ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 2GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery 3BioCis Pharma Starts Phase IIa Trial in Psoriasis 2
(Date:11/4/2009)... BIO-key International, I...-based biometric identification software is showca...ABB TXPO conference being held at the New Orleans ... will provide hands-on product demonstrations of i...ooth #424. Also, at 5 PM on Monday, October 26, Pe...
(Date:11/4/2009)...ewswire/ -- Glencoe Software, Inc., the commercial...ortium ( http://openmicroscopy.org ), is proud t...iety of Cell Biology,s exciting new project titled...warded a $2.5M stimulus grant through the National...program, as part of the American Reinvestment and ...
(Date:11/3/2009)...search report published in a recent issue of Hort...egre examined the effects of covering orchard floo...lity, canopy light distribution, orchard temperatu...med using Extenday and Solarmate films installed 5...ondial Gala, apples. The research showed that the ...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3Pennsylvanians With Disabilities Call for an End to Institution Only Options 52611 1Pennsylvanians With Disabilities Call for an End to Institution Only Options 52611 2
...- Chronic stress takes a physical and emotional to...cing together a medical puzzle to understand how w...rain. Being able to quickly and successfully resp... a rat model, Jaideep Bains, PhD, a University of ...he Hotchkiss Brain Institute have discovered that ...
...t NYU Langone Medical Center may have discovered a...S). BTHS, a sometimes fatal disease, is a serious ...that leads to infection or heart failure in childh...pendent phospholipase A2 in the pathogenesis of Ba...eedings of the National Academy of Sciences , show...
...o High levels of a protein linked to the way pain...n abdominal pain in a recent study in mice. , Re...ht someday serve as the basis of new treatments fo...isorders. , The scientists at Ohio State Universi...is protein, called EAAT2, or excitatory amino acid...
Other Biology News:New and unexpected mechanism identified how the brain responds to stress 2New potential therapeutic target discovered for genetic disorder -- Barth syndrome 2Research uncovers promising target to treat chronic abdominal pain 2Research uncovers promising target to treat chronic abdominal pain 3
...ng Kit enables you to prepare, in about two days, ...genomic DNA for subsequent use in making nested de...y construction is accomplished using easy and high...is randomly sheared by passing it through a syring...
...yrene with frosted labeling surfaces, volume gradu...ing. 100% integrity tested. Linkage: This CLS numb...h Cornings product number. If showing no availabil...number (Z71,695-2) or contact customer service for...
Mouse Anti-Human AATK Monoclonal Antibody, Unconjugated, Clone 2D10 from Abnova Corporation
SYBRGreen II RNA gel stain from Sigma-Aldrich
Biology Products: